GammaDelta Therapeutics Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:GammaDelta Therapeutics Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11106
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
GammaDelta Therapeutics Ltd (GammaDelta Therapeutics) is an immunotherapy company that develops immunotherapies for cancer and other immune related diseases. The company conducts research and development focused on exploiting tissue resident gamma delta T cells, which are conserved population of lymphocytes that contribute many immune responses and immunopathology. GammaDelta Therapeutics works in partnership with oncology and immune therapy research institutions. The company also offers development of new therapies for malignant disease. It operates offices and laboratories located in London. GammaDelta Therapeutics is headquartered in London, the UK.

GammaDelta Therapeutics Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
GammaDelta Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
GammaDelta Therapeutics Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
GammaDelta Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
GammaDelta Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
GammaDelta Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
GammaDelta Therapeutics Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
GammaDelta Therapeutics Raises Funds through Seed Financing 10
Partnerships 11
Takeda Pharma and GammaDelta Therapeutics Enter into Partnership 11
Acquisition 12
GammaDelta Therapeutics Acquires Lymphocyte Activation Technologies 12
GammaDelta Therapeutics Ltd – Key Competitors 13
GammaDelta Therapeutics Ltd – Key Employees 14
GammaDelta Therapeutics Ltd – Locations And Subsidiaries 15
Head Office 15
Recent Developments 16
Corporate Communications 16
Jun 18, 2018: GammaDelta Therapeutics Names Michael Koslowski As Chief Medical Officer 16
May 03, 2017: GammaDelta Therapeutics Expands Management Team Led by Paolo Paoletti as CEO 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
GammaDelta Therapeutics Ltd, Pharmaceuticals & Healthcare, Key Facts 2
GammaDelta Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
GammaDelta Therapeutics Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
GammaDelta Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
GammaDelta Therapeutics Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
GammaDelta Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
GammaDelta Therapeutics Raises Funds through Seed Financing 10
Takeda Pharma and GammaDelta Therapeutics Enter into Partnership 11
GammaDelta Therapeutics Acquires Lymphocyte Activation Technologies 12
GammaDelta Therapeutics Ltd, Key Competitors 13
GammaDelta Therapeutics Ltd, Key Employees 14

List of Figures
GammaDelta Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
GammaDelta Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
GammaDelta Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
GammaDelta Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
GammaDelta Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
GammaDelta Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
GammaDelta Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
GammaDelta Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[GammaDelta Therapeutics Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Nanomerics Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Nanomerics Ltd (Nanomerics) is a healthcare solution provider that develops drug delivery solutions for poorly water soluble drugs, nucleic acids and peptides. The company offers products such as METDoloron, METSporine, METAmphizon, METEnkalon, MET undisclosed, MET ocular undiscl, ocular und …
  • Tokuyama Corporation (4043)-エネルギー分野:企業M&A・提携分析
    Summary Tokuyama Corporation (Tokuyama), formerly Nihon Soda Kogyo Co., Ltd., manufactures and sells chemicals, specialty products and cement. Its product portfolio includes soda ash, caustic soda, silicon products, vinyl chloride monomer/polymer, fine chemicals, film products, medical materials, me …
  • Ryoden Trading Co Ltd:企業の戦略・SWOT・財務情報
    Ryoden Trading Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Ryoden Trading Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Consejo Superior de Investigaciones Cientificas:製薬・医療:M&Aディール及び事業提携情報
    Summary Consejo Superior de Investigaciones Cientificas (CSIC) is a research institute that offers research capacity, and human and material resources to conduct research projects. The institute offers multidisciplinary scientific and technical research, scientific and technical advice, management o …
  • Mallinckrodt LLC:医療機器:M&Aディール及び事業提携情報
    Summary Mallinckrodt LLC (Mallinckrodt), formerly Therakos Inc, a subsidiary of Mallinckrodt Plc, is a provider of autologous immune cell therapy through extracorporeal photopheresis. The company provides Therakos Cellex Photopheresis system, which is indicated for use in ultraviolet-A irradiation i …
  • Taiwan Shin Kong Commercial Bank Co., Ltd.:企業の戦略・SWOT・財務情報
    Taiwan Shin Kong Commercial Bank Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Taiwan Shin Kong Commercial Bank Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, …
  • Rosneft Oil Co (ROSN):電力:M&Aディール及び事業提携情報
    Summary Rosneft Oil Company (Rosneft) is a vertically integrated oil and gas company that explores for, develops and produces crude oil, natural gas and condensates; and refines, markets and distributes petroleum products and petrochemicals. It has exploration assets across Western Siberia, Eastern …
  • Tenneco Inc.:企業の戦略・SWOT・財務分析
    Tenneco Inc. - Strategy, SWOT and Corporate Finance Report Summary Tenneco Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Iovance Biotherapeutics Inc (IOVA):企業の財務・戦略的SWOT分析
    Iovance Biotherapeutics Inc (IOVA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Herti AD:企業の戦略・SWOT・財務情報
    Herti AD - Strategy, SWOT and Corporate Finance Report Summary Herti AD - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Yeda Research and Development Company Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Yeda Research and Development Company Ltd (Yeda), a subsidiary of Weizmann Institute of Science is a technology transfer company that provides research and science education. The company identifies and assesses research projects with commercial potential, protects the intellectual property o …
  • Printpack Inc:企業の戦略的SWOT分析
    Printpack Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Korn/Ferry International:企業の戦略・SWOT・財務情報
    Korn/Ferry International - Strategy, SWOT and Corporate Finance Report Summary Korn/Ferry International - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Dairyland Power Cooperative:企業の戦略的SWOT分析
    Dairyland Power Cooperative - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Metgasco Ltd (MEL):石油・ガス:M&Aディール及び事業提携情報
    Summary Metgasco Ltd (Metgasco) is an oil and gas exploration company. The company that acquires, explores, produces, and develops oil and gas, petroleum and hydrocarbon assets. It holds interests in Clarence Moreton Basin, an exploration license located in northern New South Wales. Metgasco supplie …
  • Spotlight Innovation Inc (STLT):製薬・医療:M&Aディール及び事業提携情報
    Summary Spotlight Innovation Inc (Spotlight Innovation), formerly American Exploration Corp is a developer of proprietary technologies designed to treat rare, emerging and neglected diseases. The company’s product pipeline includes drug candidates for the treatment of cancer derived from specialized …
  • Pt Panorama Sentrawisata Tbk:企業の戦略・SWOT・財務分析
    Pt Panorama Sentrawisata Tbk - Strategy, SWOT and Corporate Finance Report Summary Pt Panorama Sentrawisata Tbk - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Nestle USA, Inc.:企業の戦略・SWOT・財務情報
    Nestle USA, Inc. - Strategy, SWOT and Corporate Finance Report Summary Nestle USA, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Adcock Ingram Holdings Ltd (AIP):製薬・医療:M&Aディール及び事業提携情報
    Summary Adcock Ingram Holdings Ltd (Adcock Ingram) develops, distributes and markets a wide range of healthcare products. The company’s product portfolio includes consumer and over-the-counter (OTC) products; prescription products; and generic medicines. It provides medicines in the areas of cardiov …
  • Cerus Energy Group Ltd (CEA):企業の財務・戦略的SWOT分析
    Summary Cerus Energy Group Ltd (Cerus Energy), formerly Petrostar Petroleum Corp is an oil and gas company that produces methanol, DME, and petroleum and natural gas. The company offers deep well disposal, storage and terminalling services, and well management services. Its well management services …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆